AUTOLOGOUS CYTOKINE-INDUCED KILLER (CIK) IMMUNOTHERAPY IN A CASE OF DISSEMINATED TUBERCULOSIS

被引：0
|
作者：
Xu, Ping [1 ]
Xu, Jun-Chi [1 ]
Chen, Xin-Nian [1 ]
Ye, Zhi-Jian [1 ]
Wu, Mei-Ying [1 ]
机构：
[1] Fifth Peoples Hosp Suzhou, Suzhou 215000, Jiangsu, Peoples R China
来源：
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2015年 / 32卷 / 01期
关键词：
CIK; disseminated tuberculosi; immunotherapy; PHASE-I; CELLS; LYMPHOMA; TRIAL; VIVO;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
A 23-year-old woman had dry cough, fever and chest tightness for 1 months. Through thoracic CT scan and serological examination, the patient was clinically diagnosed as disseminated tuberculosis. she was given anti-tuberculosis therapy combined with autologous cytokine-induced killer (CIK) immunotherapy. Through the close follow-ups we found that after immunotherapy Her condition would have a swift improvement and she do not appear liver damage after a large doses of antibiotic therapy. In conclusion, adjuvant autologous CIK immunotherapy is an effective approach for disseminated tuberculosis.
引用
收藏
页码：83 / 86
页数：4
相关论文
共 50 条
  • [31] GENETICALLY MODIFIED CYTOKINE-INDUCED KILLER (CIK) CELLS FOR TARGETED CANCER THERAPY
    Oelsner, S.
    Rettinger, E.
    Pfirrmann, V.
    Friede, M. E.
    Wels, W. S.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S126 - S126
  • [32] ANTI-TUMOR EFFECT OF AUTOLOGOUS CYTOKINE-INDUCED KILLER (CIK) CELLS IN PATIENTS WITH ADVANCED PRIMARY HEPOTIC CARCINOMA
    Yang, S.
    Zhao, X.
    Huang, J.
    Li, H.
    Yan, Y.
    Dong, W.
    Huang, L.
    Zhang, Y.
    CYTOTHERAPY, 2015, 17 (06) : S20 - S21
  • [33] Cytokine-induced killer (CIK) cells: from basic research to clinical translation
    Guo, Yelei
    Han, Weidong
    CHINESE JOURNAL OF CANCER, 2015, 34 : 1 - 9
  • [34] Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
    Gao, Xingchun
    Mi, Yajing
    Guo, Na
    Xu, Hao
    Xu, Lixian
    Gou, Xingchun
    Jin, Weilin
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [35] Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia
    Yang, Xin-Yu
    Zeng, Hui
    Chen, Fang-Ping
    ONCOLOGY LETTERS, 2015, 9 (02) : 535 - 541
  • [36] Efficacy and Safety of Autologous Cytokine-Induced Killer (CIK) Cellular Immunotherapy Combined with Chemotherapy in Non-Small-Cell Carcinoma (NSCLC): A Meta-analysis
    Zhong, Cheng
    Tang, Haowei
    Wang, Qun
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (08) : 1722 - 1735
  • [37] Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer A meta-analysis
    Yuan, Xin
    Zhang, An Zhi
    Ren, Yi Lin
    Wang, Xue Li
    Jiang, Chen Hao
    Yang, Lan
    Liu, Chun Xia
    Liang, Wei Hua
    Pang, Li Juan
    Gu, Wen Yi
    Li, Feng
    Hu, Jian Ming
    MEDICINE, 2021, 100 (13) : E24519
  • [38] Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma
    Wu, Tao
    Leboeuf, Celine
    Durand, Sarah
    Su, Bin
    Deschamps, Marina
    Zhang, Xiaowen
    Ferrand, Christophe
    Pessaux, Patrick
    Robinet, Eric
    MOLECULAR MEDICINE REPORTS, 2016, 13 (03) : 2645 - 2654
  • [39] Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
    Ma, Yue
    Xu, Ying-Chun
    Tang, Lei
    Zhang, Zan
    Wang, Jian
    Wang, Hong-Xia
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2012, 1
  • [40] Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review
    Zhang, Yong
    Qi, Yalong
    Wang, Axiang
    Ma, Baozhen
    Fu, Xiaomin
    Zhao, Lingdi
    Gao, Quanli
    ONCOTARGETS AND THERAPY, 2017, 10 : 4687 - 4690
12345